Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020

SELL
$19.54 - $55.47 $7.83 Million - $22.2 Million
-400,605 Closed
0 $0
Q4 2019

Feb 16, 2021

BUY
$10.16 - $28.14 $4.07 Million - $11.3 Million
400,605 New
400,605 $10.9 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Perella Weinberg Partners Capital Management LP Portfolio

Follow Perella Weinberg Partners Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perella Weinberg Partners Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Perella Weinberg Partners Capital Management LP with notifications on news.